Braincool Investor Relations Material
Latest events
Q2 2025
15 Aug, 2025
Q1 2025
2 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Braincool
Access all reports
BrainCool AB is a Swedish medical device company specializing in the development, marketing, and sale of advanced medical cooling systems. The company focuses on targeted temperature management (TTM) solutions designed to protect the brain and vital organs by reducing metabolic activity and minimizing inflammation. These technologies are primarily applied in cases of cardiac arrest, stroke, and oncology-related complications such as oral mucositis caused by chemotherapy. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BRAIN
Country
🇸🇪 Sweden